
Three more Korean securities firms receive derivatives licences
Previously, securities firms could only trade OTC derivatives as end-users. Under the new regulations, however, securities firms operating in the country can market OTC derivatives to corporate and selected institutional clients after receiving approval from the FSC.
The official added that Woori Securities had also applied for a licence but later withdrew its application after failing to meet internal control system and risk management requirements.
While the new business opportunity has been met with great enthusiasm, the current regulations do not allow securities firms to market derivatives products to retail investors. However, under the new Securities and Exchange Act – expected to come into effect next week - retail products such as equity-linked notes and warrants are expected to be classified as securities. This will mean that securities firms with OTC derivatives licences will be able to market these newly classified securities to the country’s retail investors.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Structured products
Regulation
What lies beneath: Nomura’s iceberg balance sheet
Collateral received by the Japanese bank exceeds its total on-balance-sheet assets – does it matter?
Receive this by email